TAM
NVAX icon

Tucker Asset Management’s Novavax NVAX Stock Holding History

Tucker Asset Management’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-171
Closed -$3.81K – 885
2022
Q3 		$3.81K Hold
171
– – ﹤0.01% 475
2022
Q2 		$8.79K Hold
171
– – ﹤0.01% 264
2022
Q1 		$12.6K Hold
171
– – ﹤0.01% 205
2021
Q4 		$26.5K Hold
171
– – 0.01% 134
2021
Q3 		$25.4K Buy
+171
New +$37.7K 0.01% 128

Other funds holding NVAX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
HIG
Herr Investment Group Austin, Texas $1.5B AUM 29.27% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Tucker Asset Management's NVAX Position: Q4 2022 in Review

Tucker Asset Management sold out of Novavax (NVAX) in Q4 2022, closing a stake of 171 shares — an estimated $3.81K sold.

Tucker Asset Management first reported a position in NVAX in Q3 2021 and held it in 5 quarters. The position peaked at $26.5K in Q4 2021. 252 funds tracked by Wall St. Rank hold NVAX as of Q4 2022.

  • Tucker Asset Management reported no remaining Novavax position as of Q4 2022 after selling out during the quarter.
  • Tucker Asset Management sold 171 Novavax shares in Q4 2022, an estimated $3.81K.
  • Tucker Asset Management first reported a position in Novavax in Q3 2021 and held it in 5 quarters.
  • Tucker Asset Management's Novavax position peaked at $26.5K in Q4 2021.
  • 252 funds tracked by Wall St. Rank held Novavax as of Q4 2022.

Based on Tucker Asset Management's 13F filing for Q4 2022, filed 11 May 2023.